Found 11 matching trials
Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) PHASE2 Food allergy is a serious public health concern that causes potentially-lif...
Show More Location
University of California Los Angeles (UCLA)
Learn More & Join Trial
E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy PHASE2 The purpose of this study is testing the use E-B-FAHF-2 Chinese herbal ther...
Show More Location
Johns Hopkins University
Learn More & Join Trial
Low Dose Multi-OIT for Food Allergy (LoMo) PHASE2 Oral immunotherapy (OIT) is a food allergy treatment where small amounts of...
Show More Location
Hospital for Sick Children
Learn More & Join Trial
Multi-Food Oral Immunotherapy for Peanut and Tree Nuts NA This study aims to evaluate the efficacy and safety of multi-food oral immu...
Show More Location
Department of Pediatric Pulmonology, Allergology and Clinical Immunology, Institute of Pediatrics, Karol Jonscher Clinical Hospital, Poznań University of Medical Sciences
Learn More & Join Trial
Omalizumab to Accelerate a Symptom-driven Multi-food OIT PHASE2 This study will determine the dose-related efficacy of a 20-week treatment ...
Show More Status
Active Not Recruiting
Location
The Hospital for Sick Children
Learn More & Join Trial
Low Dose Multi-Nut Oral Immunotherapy in Pre-schoolers With a Multi-Nut Allergy NA The LMNOP trial will be a 2-armed, open-label, randomised controlled trial ...
Show More Location
Murdoch Children's Research Institute
Learn More & Join Trial
E-B-FAHF-2, Multi OIT and Xolair for Food Allergy PHASE2 The purpose of this study is testing the use of Enhanced-Butanol purified-F...
Show More Location
Multiple Locations
Learn More & Join Trial
Multi OIT to Test Immune Markers After Minimum Maintenance Dose PHASE2 Few studies have been conducted to optimize safety of multiple food allerge...
Show More Learn More & Join Trial
ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults PHASE1 The purpose of this study is to assess the efficacy and safety of ADP101 in...
Show More Learn More & Join Trial
Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants PHASE3 This study is a multi-center, randomized, double-blind, placebo-controlled ...
Show More Location
Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology
Learn More & Join Trial